(CYTR, SAPX, PCRX) CRWENewswire Stocks in Action

  • 0
  • 0

Good Monday Morning, Its October 31st, 2011, I’m Lynn Lumpkin with CRWENewswire Stocks In Action. CytRx Corporation - symbol CYTR - announced favorable response and safety indications from a group of patients with advanced solid tumors in the Company’s ongoing Phase 1b/2 clinical trial with INNO-206, its tumor-targeting conjugate of the commonly used chemotherapeutic agent doxorubicin.

31 Oct 2011

70 Visualizações

arts, corporation, cytr, cytrx, entertainment, pacira, pcrx, pharmaceuticals, sapx, seven

Estatísticas do vídeo



Vídeos em Destaque